What the Numbers Say

Published research on the performance and predictive accuracy of ERS's proprietary stock risk ratings — grounded in 25 years of data, 433,500+ validated data points, and zero conflicts of interest.

25+
Years of Backtested Data
9
Proprietary Ratings Studied
433K+
Data Points Validated
Latest Report
4D Rating: The Bear Market Test

The best stocks fell less. The worst stocks never recovered. A study of 2,619 companies rated on December 31, 2021 — tracked through the bear market and recovery.

March 2026 2,619 companies 2-year study
Read the Report →

All Research

Most Recent
4D

4D Rating: The Bear Market Test

The best stocks fell less. The worst stocks never recovered. 2,619 companies rated on 12/31/2021, tracked through one year of losses and two years of recovery. A+ stocks outperformed F-rated stocks by 47 percentage points.

4D

4D Rating: 25-Year Study — 433,500 Ratings

Every rating grade performed exactly as predicted across 25 years and 433,500 individual data points. A+ rated stocks earned an average excess return of +20.1% over the S&P 500. The rating gradient held without exception.

FSN

FSN Rating: 25-Year Study — 433,500 Ratings

The definitive backtest of ERS's flagship Fiduciary Stock Navigator rating. 1,500 companies rated monthly over 25 years. A+ rated stocks earned 33.3% average annual returns vs. 18.3% for the S&P 500 in the same holding periods.

4D

4D Deep Value: Seven Portfolios, Seven Winners

Seven portfolios launched on seven different dates, each built on the 4D Rating. All seven outperformed the S&P 500. Average excess return: 14.7%. Three launched when the S&P 500 subsequently declined — all three still positive.

AA

Alpha Algorithmics: 10-Year Study — Seven Models

Every one of ERS's seven Alpha Algorithmics stock selection models significantly outperformed the S&P 500 over a 10-year study period. Average excess return across all seven models: 42.8%.

FSN

FSN Top 40: 2.2× the S&P 500 in 9 Months

ERS's Fiduciary Stock Navigator identified the top 40 stocks from 1,500 companies. Nine months later: 30.0% total return, 78% positive, 2.2× the S&P 500. No rebalancing, no human override.